Insulin-like growth factor-binding protein 2 (IBP2) is considered to be an oncogene and it has been proposed as a potential biomarker in various cancers including ovarian, glioma, prostate, colorectal, pancreatic, breast, and liver [52, 53]. The gene discussed is IGFBP2; the disease is glioma.